BPC-157 + TB-500 (Wolverine Blend)

This compound combines BPC-157, a 15-amino-acid fragment of the gastric secretory protein BPC (sequence GEPPPGKPADDAGLV), with TB-500, a 43-amino-acid synthetic analog of the N-terminal actin-binding domain (residues 17-23, LKKTETQ) of Thymosin Beta-4 (Tβ4). The two peptides operate through distinct and non-overlapping molecular mechanisms.

Molecular Profile — BPC-157

BPC-157 modulates the nitric oxide (NO) system through interactions with both the NOS-NO-cGMP pathway and the NO-independent soluble guanylyl cyclase pathway. Published in vivo data documents upregulation of VEGFR2 (KDR/Flk-1) and EGR-1 transcription factor expression in rat tissue models (Seiwerth et al., 1997; Sikiric et al., Curr Pharm Des 2018). The peptide also interacts with the FAK-paxillin signaling axis, which regulates focal adhesion dynamics in cell migration assays.

Molecular Profile — TB-500

TB-500 functions primarily through G-actin sequestration. The LKKTETQ motif binds monomeric G-actin, modulating the G-actin/F-actin equilibrium and thereby influencing cytoskeletal reorganization during cell migration. Published data demonstrates TB-500-mediated activation of integrin-linked kinase (ILK) and downstream Akt/PKB phosphorylation in cardiac progenitor cells (Bock-Marquette et al., Nature 2004). TB-500 also upregulates expression of VEGF-A and HIF-1α under hypoxic culture conditions.

Published Data

BPC-157 and Tβ4 have been characterized independently across >100 published preclinical studies. BPC-157 pharmacology has been reviewed extensively by Sikiric et al. (Curr Pharm Des 2018). Tβ4/TB-500 receptor pharmacology and ILK signaling data were characterized by Bock-Marquette et al. (Nature 2004). No peer-reviewed studies have yet characterized the pharmacokinetic or pharmacodynamic interactions of the combined formulation.

Research Relevance

The blend provides a dual-mechanism compound for experimental designs examining NO/VEGF pathway signaling in conjunction with actin-dependent cytoskeletal reorganization — two mechanistically independent axes relevant to tissue biology research.